These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22740705)

  • 1. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
    Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
    Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
    Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
    Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
    Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
    Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
    Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
    Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
    BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
    Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative genetic pathways in parathyroid tumorigenesis.
    Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3775-80. PubMed ID: 10523029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
    Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
    Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
    Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
    Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1564-6. PubMed ID: 17284619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.